CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Building World-Class House of Brands

Flora Growth Corp. (NASDAQ: FLGC) recently signed a licensing agreement with Tonino Lamborghini that marked Flora Growth’s entry into the cannabis beverages market. Under the terms of the partnership, FLGC will produce and distribute Tonino Lamborghini-branded cannabis beverages across North America and Colombia. The product line, which will be produced in Florida for initial sale in U.S. states where cannabidiol (“CBD”) ingestibles are legal, will contain CBD and other premium cannabinoids, including cannabigerol (“CBG”). Tonino Lamborghini is a luxury brand operating in the high-end designer products, hotel, beverage and real estate segments. “We are excited to partner with such a well-known luxury brand as Tonino Lamborghini, which already boasts a very successful line of beverages and aligns with Flora’s portfolio of high-end products,” a recent article quotes Flora Growth CEO Luis Merchan as saying. “This partnership is yet another step in the execution of Flora’s strategic plan to build a world-class house of brands and is also a major component of our sales and distribution strategy in the lucrative U.S. market.”

To view the full article, visit https://cnw.fm/kwFSo

About Flora Growth Corp.

Flora is a cannabis company that leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. As the operator of one of the largest outdoor cultivation facilities, Flora strives to market a higher-quality premium product at below-market prices. By prioritizing natural ingredients and value-chain sustainability across its portfolio, Flora creates premium products that help consumers restore and thrive. Visit www.FloraGrowth.ca or follow @floragrowthcorp on social for more information.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Marijuana Company of America Inc. (MCOA) Expanding Reach into New Regions, Leveraging Partnerships to Facilitate Growth

Marijuana Company of America (OTC: MCOA) has taken steps to extend its reach into new regions, including Latin America, and to leverage current strategic partnerships with several companies and its wholly owned subsidiaries to facilitate growth in an industry that continues to expand despite recent setbacks. Much like other industries around the world, the marijuana market was significantly impacted by the COVID-19 pandemic. The global cannabis market, which was valued at $22.1 billion in 2020, is expected to grow at a CAGR of 13.9% during the 2021 to 2026 forecast period. Companies that MCOA has partnered with include Cannabis Global Inc. (OTC: CBGL), Eco Innovation Group Inc. (OTC: ECOX) and Natural Plant Extracts. MCOA’s wholly owned subsidiaries include hempsmart(TM), cDistro and VBF Brands. “As the company expands into new regions around the world, it intends to utilize its resources and strategic partners’ success to continue diversifying its products and services and provide consistent value to its shareholders while securing a leading position on the legal cannabis and industrial hemp markets,” a recent article reads.

To view the full article, visit https://cnw.fm/aygIn

About Marijuana Company of America Inc.

Marijuana Company of America operates and invests in the cannabis sector directly. The company’s operations include C-Distro, one of the fastest growing distribution companies in the THC, Hemp and CBD cannabis industries, and hempsmart(TM), a premium CBD company. The company’s core mission is to leverage its experience and access to capital to identify and invest in acquisitions with unique growth potential. For more information, visit www.MarijuanaCompanyofAmerica.com.

NOTE TO INVESTORS: The latest news and updates relating to MCOA are available in the company’s newsroom at http://cnw.fm/MCOA

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — How Marijuana Firms Can Save on Product Packaging

The cannabis industry is one of the hottest sectors right now. Dubbed one of the fastest-growing industries in the country, cannabis has generated billions of dollars in sales in just a few short years and created hundreds of thousands of job opportunities. But thanks to the controversial nature of the plant, companies face restrictions that make navigating the business landscape difficult. Packaging, for instance, can be quite tricky as some jurisdictions have placed stringent packaging requirements on cannabis products.

Keeping product packaging costs low may require some creative thinking, but it isn’t impossible. MJBizDaily talked to a number of hemp and marijuana stakeholders about how they saved money on packaging, and they provided a treasure trove of information. Eric Leslie, the co-owner and chief marketing officer of Cheeba Chews in Boulder, Colorado, first cautions against going too cheap. It’s not always the most cost-effective tactic because going for cheap package providers may result in random defective units, print errors and inconsistent-looking packages.

Leslie says that even if you do land a cheap contract with a packaging provider, make sure you always have a backup option. Some suppliers will give you low-ball estimates to attract you then steadily raise the price on future orders. Having a competing bid from another supplier can keep the prices in check.

Shannon Reed, the chief marketing officer of Santa Monica, California-based Omura, says that you should opt for smaller, lightweight packaging. This will reduce storage space, shipping costs, and package production time, as well as being less wasteful.

Additionally, using a limited number of colors and print methods will reduce the overall amount of work needed to manufacture the packaging. Jonathan Persofsky, the cofounder and CEO of Toronto-based Green Gruff, concurs, saying that you should avoid excessive packaging as customers are becoming more conscious of their carbon footprints and are less likely to opt for wasteful products. Reed also talks about choosing the correct base material for your packaging; unsuitable paper may require extra interventions and additional tertiary packaging in the future.

Samip Shah, chief operating officer at C3 Industries in Detroit, says the quality and construction of the packaging material should be a top consideration. You want to protect the products inside from as much damage as possible, he notes. Keep it simple too, he adds.

Trent Woloveck, chief commercial director at Florida-based Jushi Holdings, is of the same opinion, stating that you should go for simple, attractive packaging. Flashy and colorful packages are both expensive and environmentally wasteful, he says. Your packaging of choice should be durable and look attractive to capture customers’ attention.

At the end of the day, he says, customers simply want an effective and high-quality product that’s affordable. If you saddle them with additional costs due to flashy, wasteful and expensive packaging, they will find another product that’s affordable and has a reduced environmental impact.

Such wasteful packaging may be hard to find among companies such as Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF), which are constantly looking out for additional ways to optimize every aspect of their operations.

NOTE TO INVESTORS: The latest news and updates relating to Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) are available in the company’s newsroom at https://cnw.fm/RWBYF

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Thailand Set to Expand Laws on Cannabis Use

Authorities in Thailand plan to extend the scope of cannabis use in the country, which has been afflicted by the availability of cheap narcotics. In a recent interview, Anutin Charnvirakul, the country’s Minister of Health, stated that he was advocating for a new legislation that would allow licensed marijuana cultivators to use whole plants for commercial and medicinal purposes. Current law opposes this, with licensed growers only being allowed to use the plant’s stalks, stems, leaves and roots.

The partial ban on the plant’s other parts was approved during the country’s legalization process for cannabis as the cannabis plant’s seeds, buds and flowers usually contain high amounts of THC. THC is the main psychoactive component found in the marijuana plant, which induces a high.

Anutin stated that by the end of 2022, the use of the entire marijuana plant will be legalized, urging licensed cultivators to produce more plants for supplementary income. Under the new law, every household will also be permitted to grow six plants of marijuana for limited sales to add to their income and also for personal use.

Legislators hope that this initiative will enable farming families to grow cannabis and use the plant to make cosmetic products or sell their produce to hospitals run by the government as part of a project to generate income. Earlier in the year, the health minister told cultivators in northeastern Thailand that hemp and cannabis were economic crops and could be used to generate revenue.

He added that government officials were focused on easing restrictions to allow easier access to the crop, noting that he hoped people would use it correctly. The Health Ministry is hopeful that the legalization of cannabis will lead to a decline in the availability and/or use of heroin and cheap methamphetamines such as yaba, as well as the use of illegally produced cannabis.

In November, law enforcement officials seized large amounts of illegally trafficked narcotics, including hundreds of kilograms of illegally produced cannabis, several hundred kilograms of crystal meth and a couple million pills of methamphetamine. The Narcotics Suppression Bureau believes that most of the illegally trafficked narcotics are brought into the country from the Shan state in Myanmar through various borders. At the moment, the use of cannabis for recreational purposes is banned in the country.

The plant’s medical use is permitted, however, with individuals suffering from specific medical conditions being allowed to use the herb for medicinal purposes at wellness centers, hospitals and other facilities.

At this rate of cannabis legalization, companies such as Simply Sonoma Inc. could soon find themselves having a huge international market to service.

NOTE TO INVESTORS: The latest news and updates relating to Simply Sonoma Inc. are available in the company’s newsroom at https://cnw.fm/Sonoma

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Genius’ Flagship Innovation Revealed as Mystery Cannabis Pipe Smoked on ‘Sex and the City’ Reboot

Viewers noticed an unusual cannabis device being smoked in episodes one and two of the new HBOMax Series, “And Just Like That.” As it turns out, the device is a Genius Pipe that is shown in the premier episode of the “Sex and the City” reboot, where Carrie is clearly envious as Che lights up a sleek flat pipe and takes a hit as they ride an elevator together. In the second episode, Miranda catches her son Brady smoking weed. The same mystery pipe is dropped hard on the ground; however, the apparently sturdy pipe is undamaged and goes back into a pocket. The elegantly shaped and sexy Genius Pipe, which uses patented technology to deliver cooled and filtered smoke, is known for its exceptional ability to accentuate the flavor of cannabis. While the pipe’s appearance on the show was a surprise to Genius, the cannabis lifestyle brand behind the Genius Pipe, the creators of the device understand its appeal. “We were watching the show like everybody else when we found out,” said Dyan Ferman, CEO of Genius. “We’re thrilled. But not totally surprised. Genius pipes make sense for modern cannabis users who appreciate style, design and functionality.”

To view the full press release, visit https://cnw.fm/rCZlX

About Genius

Genius is a modern cannabis lifestyle brand, built around its flagship innovation, the Genius Pipe. Genius Pipe is the ultimate cannabis tasting pipe, selected by elite connoisseurs of fine herb for its unique cooling and filtering functionality and ultra-stylish design. Genius Pipe is available in a variety of styles, including bespoke models with custom engraving. The Genius lifestyle platform also features High-End CBD products, fashionable wear and accessories. Genius Pipe has been providing premium products in the United States and abroad since 2014 and has been featured in GQ Magazine, The Daily Beast, High Times, Touch of Modern and endorsed by many influencers in the worlds of music, sports, business and fashion. For more information, visit www.GeniusPipe.com.

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – AmeriCann Inc.’s (ACAN) Massachusetts Cannabis Center Featured on Award-Winning Series

AmeriCann (OTCQB: ACAN), a cannabis company that develops state-of-the-art cultivation, product manufacturing and distribution facilities, today announced that its Massachusetts Cannabis Center was featured on the award-winning series by Dr. Sanjay Gupta on CNN exploring cannabis treatments for autism. “For nearly a decade Dr. Sanjay Gupta’s breakthrough series has shattered myths and introduced the healing properties of cannabis on a global stage,” said AmeriCann CEO Tim Keogh. “We are proud to play a role in helping Dr. Gupta present the considerable benefits that severe autism patients have achieved being treated with cannabis.” To view the full press release, visit https://cnw.fm/fIF9L About AmeriCann Inc. AmeriCann develops and leases cannabis cultivation, processing and product manufacturing facilities. The company uses greenhouse technology, which is superior to the current industry standard of growing cannabis in warehouse facilities under artificial lights. According to industry experts, by capturing natural sunlight, greenhouses use 25% fewer lights, and utility bills are up to 75% less than in typical warehouse cultivation facilities. As such, AmeriCann’s “Cannopy” cultivation system enables cannabis to be produced with a greatly reduced carbon footprint, making the final product less expensive. Additionally, greenhouse construction costs are nearly half of warehouse construction costs. AmeriCann is also designing GMP certified cannabis extraction and product manufacturing infrastructure. The company has secured licenses to produce cannabis infused products including beverages, edibles, topicals and concentrates. AmeriCann plans to operate a marijuana product manufacturing business at the Massachusetts Cannabis Center. For more information about the company, visit www.AmeriCann.co. About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer Do you have questions or are you interested in working with CNW? Ask our Editor CannabisNewsWire (CNW) Denver, Colorado www.CannabisNewsWire.com 303.498.7722 Office Editor@CannabisNewsWire.com CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Partners with Avicanna to Launch New Derma-Cosmetic Brand

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, is working with Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) to unveil a new THC-free, CBD derma-cosmetic brand. The first known CBD skincare line to be clinically tested and commercialized across four international markets, Pura H&W will include seven SKUs of proprietary products. The products are formulated using a combination of purified CBD and other synergistic botanical ingredients designed to naturally regulate and nourish the skin. The Pura H&W product line was developed by Avicanna and specific products have undergone clinical trials. The products are available under Pura H&W or Pura Earth in Canada, Colombia, Ecuador and the U.S. Consumers can purchase Pura H&W products online as well as from both cannabis and noncannabis specific retailers. Avicanna is a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based pharmaceuticals. “We are excited to launch the Pura brand in the U.S., said Red White & Bloom CEO Brad Rogers in the press release. “As the first clinically tested line in CBD cosmetics, the reaction from our stores and retail partners has been exciting and this is strategically aligned with our goal to be the most recognized and responsible multi state operator (MSO) in the market. We look forward to scaling the launch quickly in both our physical and digital channels.”

To view the full press release, visit https://cnw.fm/KQVAC

About Red White & Bloom Brands Inc.

Red White & Bloom Brands is positioning itself to be one of the top-three multistate cannabis operators active in the U.S. legal cannabis and hemp sectors. RWB is predominantly focusing its investments on major U.S. markets, including Michigan, Illinois, California and Florida with respect to cannabis, as well as the United States and internationally for hemp-based CBD products. For more information about the company, please visit www.RedWhiteBloom.com.

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://cnw.fm/RWBYF

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Malta Becomes First Country in EU to Legalize Marijuana

Malta, an island-state located in the Mediterranean Sea, has become the first nation in the European Union to legalize the personal use and growing of marijuana. This move by Malta comes after the United Nations reclassified marijuana to recognize its therapeutic use in 2020.

Adults in the country will be allowed to grow a maximum of four plants in their homes and be in possession of up to seven grams of marijuana. However, smoking the herb in front of children or smoking it in public remains illegal.

The parliament of Malta voted in favor of the measure to legalize earlier this week, approving the reform with a vote of 36 to 27. Owen Bonnici, the country’s equality minister, stated that the move would prevent small-time users of marijuana from being arrested and limit drug trafficking by ensuring that users had a regularized and safe way to obtain marijuana.

The Nationalist Party, the country’s opposition party, voted against the reform. Bernard Grech, the opposition party’s leader, had warned that the reform would strengthen the illicit drug market and allow organized crime to take advantage.

Despite its approval in parliament, opponents are calling for President George Vella to not sign the reform into law. Signing the measure into law is the final stage, which requires the president’s approval.

Under the new law, any individual found in possession of more than 7 grams but less than 28 grams of cannabis could receive a fine of up to €100, which is equal to $112. Those caught smoking marijuana in front of any person below 18 will be fined €500 ($659) while those caught smoking in public will be fined €235 ($310).

Additionally, associations that will oversee the distribution of seeds to grow marijuana or the drug will be established. Legislators believe that this will regulate how much an individual can purchase, as every individual will be allowed to be a member of only a single association.

Minors found in possession of marijuana will, instead of facing criminal charges or arrest, be recommended with a treatment of care plan.

The first country to legalize marijuana for personal use globally was Uruguay, which legalized the subtance in 2013, with Canada following suit in 2018. Several other countries, including Switzerland, Luxembourg and Germany, recently announced their plans to set up legally regulated markets.

Nations such as the Netherlands tolerate the use of marijuana in its famous marijuana cafes, despite the plant being illegal in the country. In the United States, some states have legalized marijuana for recreational and/or medical use. However, the herb is still federally illegal.

For companies such as BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) that have their eye on a large market spanning different jurisdictions, Malta’s decision to end cannabis prohibition can be seen as a watershed moment since several other countries in the EU are likely to follow suit.

NOTE TO INVESTORS: The latest news and updates relating to BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) are available in the company’s newsroom at http://cnw.fm/BVNNF

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Why Cannabis May Be Helpful During Opioid Recovery

The opioid epidemic has wreaked havoc across America for nearly two decades. From 1999 to 2019, opioid overdoses claimed 841,000 lives and reached a record high of 93,000 lives lost during the coronavirus pandemic in 2020. Even though we’ve known about the opioid epidemic for more than 20 years, we are still a long way from finding an effective alternative for pharmaceuticals and eliminating overdose deaths. Ironically, one of the most controversial plants in the country may be the key to helping people recover from opioid addiction.

Dozens of states now allow qualifying patients to use medical marijuana as a treatment for a variety of health issues. Although cannabis research is still in its infancy, several studies have found that cannabis can be effective against certain conditions. With no end to the opioid crisis in sight, cannabis may be used to help people who have become addicted to opioids overcome the addiction. Several legislators are already working on federal cannabis legalization, and the plant may soon be decriminalized and even more accessible to the general public than it is now.

But how exactly does cannabis aid in opioid recovery? For starters, it can be quite effective against the one symptom that keeps addicts from recovering: withdrawal. Opioid withdrawal symptoms can be brutal. How long withdrawal symptoms last typically depends on the type of drug, amount, and frequency of use. However, cannabis can ease these symptoms and make the initial period of treatment, which can be challenging, more bearable. Studies have shown that it can relieve common withdrawal symptoms such as chronic pain, insomnia, anxiety and nausea.

Cannabis can also be effective at reducing and even eliminating opioid cravings. While everyone has everyday cravings, we can usually choose whether or not to act on them. However, it can be hard to fight cravings for addictive substances such as nicotine, alcohol and opioids once an individual is hooked. A recent study on heroin use disorder found that cannabis can reduce drug cravings and anxiety in patients recovering from opioid addiction. Test subjects exhibited a reduction in opioid craving as well as anxiety for a week after taking a dose of cannabidiol (“CBD”).

Finally, cannabis can improve the quality of life of individuals recovering from opioid addiction. Opioid withdrawal symptoms range from uncomfortable to severe and can last for months. Cannabis can ease all the negative effects of opioid withdrawal during this period and help patients regain their lives as they were before addiction set in.

The possibility that marijuana products could be helpful to those battling opioid dependence makes it worthwhile for rigorous research to be done using products manufactured by entities such as American Cannabis Partners since this is what people access when they pay a dispensary a visit in states where marijuana is legal.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Pursuing Regulatory Approvals for DehydraTECH(TM), Entry into Different Markets

Lexaria Bioscience Corp. (NASDAQ: LEXX) is embarking on new programs as well as extending ongoing ones as it pursues regulatory approvals and entry into different market sectors. In January 2022, the company expects to report blood pressure findings from its third human hypertension study, HYPER-H21-3, building on the successes of the first two human studies that evidenced effective, sustained and safe blood pressure reduction with DehydraTECH-CBD. The company will also be expecting approvals for the protocols around its fourth hypertension study, HYPER-H21-4, which is just one of the many planned studies slated for 2022. “Others include HOR-A22-1, a pharmacokinetic study to evaluate DehydraTECH’s ability to improve the delivery characteristics of estrogen; DEM-A22-1, an efficacy modeling study to evaluate DehydraTECH-CBD with and without nicotine for the potential treatment of dementia; RHEUM-A22-1, an efficacy modeling study to investigate the ability of DehydraTECH-CBD to potentially affect the treatment of rheumatoid disease; and DIAB-A22-1, an efficacy modeling study to explore DehydraTECH-CBD’s ability to potentially impact treatment of diabetes,” explains a recent article. “In addition to fulfilling Lexaria’s goal to enter into new, different multibillion markets, the four animal studies will mark the company’s push to help patients living with these conditions, some of which are potentially fatal.”

To view the full article, visit https://cnw.fm/93Tti

About Lexaria Bioscience Corp.

Lexaria’s patented drug delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce time of onset from one to two hours to minutes, and mask unwanted tastes. The technology is also being evaluated for orally administered anti-viral drugs, non-steroidal anti-inflammatory drugs (“NSAIDs”), PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 23 patents granted and over 50 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.